Customized Choice of Oral P2Y12 Receptor Blocker
A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 4000 participants.
Also called NCT01477775
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 4,000 participants
- Registry
-
NCT01477775
-
- Start date
- (registry gives no type)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Italy
- Registry status
- Unknown status
Technical summary
Registry record NCT01477775. Randomized; no masking; primary purpose treatment. Start 2012-01 (registry gives no type); primary completion 2014-12 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Customized Choice of Oral P2Y12 Receptor Blocker
- Acronym
- PRU-MATRIX
- Condition
- Acute Coronary Syndrome
- Condition
- Coronary Angioplasty
- Intervention (Drug)
- Oral P2Y12 receptor blocker
- Intervention (Drug)
- Customized choice for the oral P2Y12 receptor blocker
- Lead sponsor
- Italian Society of Invasive Cardiology
- Collaborator
- Eustrategy
Record details
- Record id
cardio:ct-nct01477775- Content hash
3b6aff832529d029fb758f8c21842871766c2b6deb0e89ce1c298bac3bf4085f